List of Biotest AG patents

Patents where

Current Assignee

Name

Biotest AG

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11325964 Process for preparing immunoglobulin compositions	Patent 11325964 was granted and assigned to Biotest AG on May, 2022 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	11325964	May 10, 2022
‌ US Patent 7452981 Humanized anti-CD4 antibody with immunosuppressive properties	Patent 7452981 was granted and assigned to Biotest AG on November, 2008 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	7452981	November 18, 2008
‌ US Patent 9221914 Agents targeting CD138 and uses thereof	Patent 9221914 was granted and assigned to Biotest AG on December, 2015 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	9221914	December 29, 2015
‌ US Patent 11517621 Treatment of severe community acquired pneumonia	Patent 11517621 was granted and assigned to Biotest AG on December, 2022 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	11517621	December 6, 2022
‌ US Patent 9512226 Agent for treating disease	Patent 9512226 was granted and assigned to Biotest AG on December, 2016 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	9512226	December 6, 2016
‌ US Patent 9550831 Method for treating psoriasis	Patent 9550831 was granted and assigned to Biotest AG on January, 2017 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	9550831	January 24, 2017
‌ US Patent 9605066 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)	Patent 9605066 was granted and assigned to Biotest AG on March, 2017 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	9605066	March 28, 2017
‌ US Patent 9334325 Method for treating psoriasis	Patent 9334325 was granted and assigned to Biotest AG on May, 2016 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	9334325	May 10, 2016
‌ US Patent 7659247 Production of a von Willebrand factor preparation having a high specific activity	Patent 7659247 was granted and assigned to Biotest AG on February, 2010 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	7659247	February 9, 2010
‌ US Patent 9995733 Agents for treating disease	Patent 9995733 was granted and assigned to Biotest AG on June, 2018 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	9995733	June 12, 2018
‌ US Patent 9518110 Antibody preparations	Patent 9518110 was granted and assigned to Biotest AG on December, 2016 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	9518110	December 13, 2016
‌ US Patent 9243056 Process for preparing an immunoglobulin composition	Patent 9243056 was granted and assigned to Biotest AG on January, 2016 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	9243056	January 26, 2016
‌ US Patent 10059759 Antibody preparations	Patent 10059759 was granted and assigned to Biotest AG on August, 2018 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	10059759	August 28, 2018
‌ US Patent 8685651 Method for screening for an anti-CD4 antibody suitable for use in immunotherapy	Patent 8685651 was granted and assigned to Biotest AG on April, 2014 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	8685651	April 1, 2014
‌ US Patent 9758581 Humanized anti-CD4 antibody with immunosuppressive properties	Patent 9758581 was granted and assigned to Biotest AG on September, 2017 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	9758581	September 12, 2017
‌ US Patent 7863420 Process for removing fibronectin from plasma fractions	Patent 7863420 was granted and assigned to Biotest AG on January, 2011 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	7863420	January 4, 2011
‌ US Patent 8900806 Antibody preparations	Patent 8900806 was granted and assigned to Biotest AG on December, 2014 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	8900806	December 2, 2014
‌ US Patent 8440806 Humanized anti-CD4 antibody with immunosuppressive properties	Patent 8440806 was granted and assigned to Biotest AG on May, 2013 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	8440806	May 14, 2013
‌ US Patent 7939643 Production of a von Willebrand factor preparation using hydroxylapatite	Patent 7939643 was granted and assigned to Biotest AG on May, 2011 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	7939643	May 10, 2011
‌ US Patent 9540436 Use of antibodies for detection of IL-10	Patent 9540436 was granted and assigned to Biotest AG on January, 2017 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	9540436	January 10, 2017
‌ US Patent 10954290 IgG, IgA and IgM antibody preparations, method of making and method of use in treatment	Patent 10954290 was granted and assigned to Biotest AG on March, 2021 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	10954290	March 23, 2021
‌ US Patent 10918715 Treatment of severe community acquired pneumonia	Patent 10918715 was granted and assigned to Biotest AG on February, 2021 by the United States Patent and Trademark Office.	Biotest AG	Biotest AG	United States Patent and Trademark Office	10918715	February 16, 2021
‌ US Patent 8956607 Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE)	Patent 8956607 was granted and assigned to Biotest AG on February, 2015 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	8956607	February 17, 2015
‌ US Patent 8673304 Humanized anti-CD4 antibody with immunosuppressive properties	Patent 8673304 was granted and assigned to Biotest AG on March, 2014 by the United States Patent and Trademark Office.		Biotest AG	United States Patent and Trademark Office	8673304	March 18, 2014
‌ US Patent 8852871 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)			Biotest AG	United States Patent and Trademark Office	8852871	October 7, 2014

Results per page:

28 results

0 selected

28 results

0 selected